CAS: 3921-01-5; 2,4-Dibromopyrimidine

该化合物是一种杂交有机化合物,其特征是2和4个位置上用两颗溴原子取代一个火水环,其分子式为C4H2BR2N2,表明碳,氢,溴和氮原子的存在.该化合物一般是白到光黄色晶状固体,以其在极有机溶剂中的中溶性而著称. 2,4-二溴丙胺主要用于合成各种制药和农用化学品,因为它能够作为有机合成的建筑块.溴原子的存在增强了其再活性,使它成为了更复杂的分子的中间体.此外,它展示了生物活动,可以在药用化学中加以利用.在处理该化合物时,应当注意安全防范,因为如果浸入或吸入,可能会对健康造成危害,因此应当采用适当的处置方法来减轻环境影响.

结构式图片

相似化合物

36847-11-7 1187931-22-1 36847-10-6

欧盟法规

C&L通报

上下游产品

CAS号4595-60-2 2-溴嘧啶 | CAS号66-22-8 尿嘧啶 | CAS号3934-20-1 2,4-二氯嘧啶 | CAS号25095-48-1 2,4-diphenylpyr...

合成工艺路线路线简述

  • 合成目标产物 2,4-Dibromopyrimidine 主要起始原料 Uracil
  • (文献来源)合成步骤主要原料 Uracil

专利信息


专利号:US-2024335420-A1
优先权日:2021-08-02
标题:N-acylhydrazone compounds capable of inhibiting nav 1.7 and/or nav 1.8, processes for the preparation thereof, compositions, uses, methods for treatment using same and kits
发明人:BARREIRO GABRIELA; SANT'ANA DANILO PEREIRA DE; GAMBA LUIS EDUARDO REINA; FRAGA CARLOS ALBERTO MANSSOUR; BARREIRO ELIEZER JESUS DE LACERDA; LIMA LÃ?DIA MOREIRA
权利人:EUROFARMA LABORATORIOS S A; UNIV FEDERAL DO RIO DE JANEIRO UFRJ
摘要:N-Acylhydrazone compounds that are Nav 1.7 and/or Nav 1.8 inhibitors, including N-acylhydrazone compounds of Formula (I), wherein substituents R1 to R4 are independently selected from the groups defined in the specification, as well as to the processes for the preparation thereof, compositions comprising at least one of these compounds, uses, treatment methods for treating or preventing pain-related pathologies, and kits, useful in the fields of medicinal chemistry, organic synthesis, as well as in the treatment of pain-related disorders.

专利号:US-10870626-B2
优先权日:2014-09-26
标题:Process for preparing (cyclopentyl[d]pyrimidin-4-yl)piperazine compounds
发明人:GOSSELIN FRANCIS; HAN CHONG; IDING HANS; REENTS REINHARD; SAVAGE SCOTT; WIRZ BEAT
权利人:HOFFMANN LA ROCHE; GENENTECH INC
摘要:The present disclosure relates to processes for preparing (cyclopentyl[d]pyrimidin-4-yl)piperazine compounds, and more particularly relates to processes for preparing (R)-4-(5-methyl-7-oxo-6,7-dihydro-5H-cyclopenta[d] pyrimidin-4-yl)piperazine and N-protected derivatives thereof, which may be used as an intermediate in the synthesis of Ipatasertib (i.e., (S)-2-(4-chlorophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)-3-(isopropylamino)-propan-1-one). The present disclosure additionally relates to various compounds that are intermediates employed in these processes.

专利号:EP-3626710-B1
优先权日:2014-09-26
标 题 :Process for preparing an intermediate in the synthesis of (cyclopentyl[d]pyrimidin-4-yl)piperazine compounds

专利号:CN-114057655-B
优先权日:2021-12-13
标 题 :A kind of synthesis method of dibromo compound
安徽美洛医药科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.merlotpharma.com
企业联系电话:13776899539👤
📞安徽美洛医药科技有限公司 ⚠️参考联系方式
联系人:王先生
电话:13776899539
手机:13776899539

邮箱:sales@merlotpharma.com
通信地址: 安徽省马鞍山市花山区慈湖高新区陶甸路155号宁马科创园7号楼3楼
邮编:
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:安徽省马鞍山市花山区慈湖高新区陶甸路155号宁马科创园7号楼3楼
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:von Angerer, S., Science of Synthesis Knowledge Updates, (2011) 1, 356.
摘要:von Angerer, S., Science of Synthesis Knowledge Updates, (2011) 1, 366.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知